OBSOLETE: Lymphoproliferative syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:238510
Who is this for?
Show terms as
2Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Lymphoproliferative syndrome is a term that has been used to describe a group of conditions where the immune system produces too many white blood cells called lymphocytes. This entry in Orphanet (code 238510) is now marked as OBSOLETE, meaning it has been retired and replaced by more specific disease classifications. The conditions previously grouped under this name are now categorized under more precise diagnoses such as autoimmune lymphoproliferative syndrome (ALPS), X-linked lymphoproliferative disease (XLP), or other specific lymphoproliferative disorders. In these conditions, the body's lymphocytes grow and multiply in an uncontrolled way, which can lead to enlarged lymph nodes, an enlarged spleen, an enlarged liver, and problems with the immune system. Some forms are inherited and caused by genetic mutations that affect how lymphocytes normally die off when they are no longer needed. Without proper cell death (called apoptosis), these extra immune cells build up and can cause autoimmune problems, where the body attacks its own healthy tissues. Because this is an obsolete classification, patients who were previously diagnosed under this umbrella term should work with their doctors to determine which specific lymphoproliferative condition they have. Treatment varies widely depending on the exact diagnosis but may include immunosuppressive medications, targeted therapies, monitoring for lymphoma, and in some cases bone marrow transplantation.

Key symptoms:

Swollen lymph nodes throughout the bodyEnlarged spleenEnlarged liverFrequent or unusual infectionsLow red blood cell count (anemia)Low platelet count causing easy bruising or bleedingFatigue and tirednessFever without clear causeAutoimmune problems where the body attacks its own cellsSkin rashesUnexplained weight lossNight sweats

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

2 events
Mar 2025Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE2

TrialRECRUITING
Feb 2022Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Lymphoproliferative syndrome.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
Phase 21 trial
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
Phase 2
Actively Recruiting
PI: V. Koneti Rao, M.D. (National Institute of Allergy and Infectious Disea) · Sites: Bethesda, Maryland; Philadelphia, Pennsylvania +1 more · Age: 16120 yrs
Other1 trial
Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
Actively Recruiting
PI: Pier Luigi Zinzani, MD (IRCCS Azienda Ospedaliero-Universitaria di Bologna) · Sites: Bologna, Bologna · Age: 1899 yrs

No specialists are currently listed for OBSOLETE: Lymphoproliferative syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Lymphoproliferative syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Lymphoproliferative syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Lymphoproliferative syndrome.

Start the conversation →

Latest news about OBSOLETE: Lymphoproliferative syndrome

No recent news articles for OBSOLETE: Lymphoproliferative syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific type of lymphoproliferative syndrome do I or my child have?,What genetic testing should be done to confirm the diagnosis?,What is the risk of developing lymphoma, and how will you monitor for it?,What medications are recommended, and what are their side effects?,Is bone marrow transplant an option for my specific condition?,Are other family members at risk and should they be tested?,What symptoms should prompt me to go to the emergency room?

Common questions about OBSOLETE: Lymphoproliferative syndrome

What is OBSOLETE: Lymphoproliferative syndrome?

Lymphoproliferative syndrome is a term that has been used to describe a group of conditions where the immune system produces too many white blood cells called lymphocytes. This entry in Orphanet (code 238510) is now marked as OBSOLETE, meaning it has been retired and replaced by more specific disease classifications. The conditions previously grouped under this name are now categorized under more precise diagnoses such as autoimmune lymphoproliferative syndrome (ALPS), X-linked lymphoproliferative disease (XLP), or other specific lymphoproliferative disorders. In these conditions, the body's

Are there clinical trials for OBSOLETE: Lymphoproliferative syndrome?

Yes — 2 recruiting clinical trials are currently listed for OBSOLETE: Lymphoproliferative syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.